Soluble TREM2 (sTREM2), generated through proteolytic cleavage of the full-length protein by metalloproteinase 10 (ADAM10) and ADAM17, is a biologically active molecule capable of ligand binding, microglial activation, and immune response modulation in the AD continuum [40]. Here, TREM2 is linked to Alzheimer disease.